Breast Cancer
5748 clinical trials
374 cell line models
35 approved drugs
Breast Cancer
Molecular Synopsis
Drugs and clinical candidates

35 drugs have received FDA approval for Breast Cancer:

  • Abemaciclib
  • Anastrozole
  • Atezolizumab
  • Capecitabine
  • Cyclophosphamide

564 drugs have a clinical trial registered for Breast Cancer.

22050 compounds have been tested in Breast Cancer (13503 <= 500nM potency).

Sources:,, ChEMBL.

Clinical trials
There are 5748 clinical trials for Breast Cancer, 3385 of which have one or more drug interventions, 2363 with no drug intervention.
Cell line models

There are 374 Cell Line Models for Breast Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from mesh condition terms to Breast Cancer:
  • Hereditary Breast and Ovarian Cancer Syndrome
  • Breast Carcinoma In Situ
  • Carcinoma, Intraductal, Noninfiltrating
  • Inflammatory Breast Neoplasms
  • Breast Neoplasms, Male
The following terms have been mapped from to Breast Cancer:
  • Breast cancer in women who are at high risk for the disease
  • Breast cancer. It is also used as adjuvant therapy for breast cancer that has spread to the lymph nodes after surgery
  • Breast cancer that is HER2 positive (HER2+). It is used:In patients with metastatic disease that has not been treated with hormone therapy or chemotherapy
  • Breast cancer. It is used in combination with exemestane in postmenopausal women with advanced hormone receptor??????positive (HR+) breast cancer that is also HER2 negative (HER2-) and has not gotten better after treatment with letrozole or anastrozole
  • Locally advanced or metastatic breast cancer that is HR+ or hormone receptor unknown (it is not known whether it is HR+ or hormone receptor??????negative). It is used as first-line therapy in these patients